A Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations

NCT06370351 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

OTOF Gene Mutation
DFNB9
Congenital Deafness
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Deafness
Hearing Loss, Sensorineural

Interventions

COMBINATION_PRODUCT: SENS-501 administration

Sponsor

Sensorion